ClinicalTrials.gg
Drug

Sunitinib clinical trials

Also written Sutent, SU011248 and SU11248.

Includes 1 study of Sunitinib maleate.

studies test it
323
open now
13
in phase 3
19
first study started
2003

How each study uses Sunitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Sunitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Jan 2006 · SUTENT · NDA 021938 (FDA, Drugs@FDA)
European Union
19 Jul 2006 · Sutent · EMEA/H/C/000687 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sunitinib
191
sunitinib malate
117
Sutent, SU011248
5
sunitinib (Sutent)
4
Sunitinib Malate (SU011248)
4

Brand

Sutent
144

Development codes

SU011248
54
SU11248
52
SU010398
3
PHA-290940AD
3
GB-102
2

Studies by the year they started

323 studies that test it; most in 2007 (71)

Studies that test Sunitinib, by start year
YearStudies
20033
20046
200513
200641
200771
200849
200938
201018
201110
201213
20138
20146
20157
20168
201710
20186
20197
20212
20221
20232
20243
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
79
Phase 2
227
Phase 3
19
Phase 4
8
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 76 · Other 247

Pfizer (58) · National Cancer Institute (NCI) (39) · M.D. Anderson Cancer Center (10) · Memorial Sloan Kettering Cancer Center (9) · Amsterdam UMC, location VUmc (6) · Case Comprehensive Cancer Center (6) · Massachusetts General Hospital (6) · University Health Network, Toronto (5)

Often tested with

Tested in the same studies.

Erlotinib (10) · Gemcitabine (10) · Cisplatin (9) · Sorafenib (7) · Pazopanib (7) · Bevacizumab (7) · Capecitabine (7) · Crizotinib (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 12 phase 3 studies under way

Sunitinib is the comparator. A study of two new drugs counts under both.

  • 2Savolitinib · AstraZeneca
  • 2Benmelstobart · Sun Yat-sen University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · next primary completion Jun 2027
  • 2Ripretinib · Deciphera Pharmaceuticals, LLC · next primary completion Dec 2027
  • 2Everolimus · Eisai Inc., Peking University Cancer Hospital & Institute · next primary completion Dec 2028
  • 1Atezolizumab · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Niraparib · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Cabozantinib · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Durvalumab · AstraZeneca
Reaching primary completion within a year · 8

Studies that test Sunitinib.

Studies

Open first, then newest update. How each study uses Sunitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 323

See all 323 studies that test Sunitinib →

Given beside what is tested · 45 — Sunitinib is usual care or a partner of the new treatment

Showing 20 of 45.

As the comparator · 39 — what is tested is compared with Sunitinib

Showing 20 of 39.

Codes

What other systems call Sunitinib · ClinicalTrials.gg INT006665

  • MeSH (NLM) D000077210SunitinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) V99T50803MSUNITINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 357977Confirmed FDA, Wikidata
  • Wikidata Q417542sunitinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C71622SunitinibOne source FDA
  • DrugBank DB01268One source Wikidata

Also registered as sunitinib malate (UNII LVX8N1UT73 · RxNorm 616275).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.